Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease
- PMID: 1992362
- DOI: 10.1212/wnl.41.2_part_1.202
Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease
Abstract
We evaluated whether patients with young-onset Parkinson's disease (PD) (onset between 21 and 40 years) develop levodopa-induced dyskinesias and motor response fluctuations more frequently and earlier than patients with older-onset PD (onset after 40 years) by determining the period from levodopa introduction to development of dyskinesias or fluctuations in 25 young-onset (mean age at onset, 33.54 years) and in 25 matched older-onset PD patients (mean age at onset, 55.76 years). Young-onset PD patients had significantly higher frequency for both dyskinesias and fluctuations after both 3 and 5 years of levodopa. Young-onset PD patients also developed both levodopa-induced dyskinesias and fluctuations earlier than older-onset PD patients. We suggest that the introduction of levodopa therapy in patients with young onset PD should be postponed as long as possible.
Similar articles
-
Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease.J Parkinsons Dis. 2015;5(4):847-53. doi: 10.3233/JPD-150532. J Parkinsons Dis. 2015. PMID: 26444087
-
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.Brain. 2014 Oct;137(Pt 10):2731-42. doi: 10.1093/brain/awu195. Epub 2014 Jul 17. Brain. 2014. PMID: 25034897 Free PMC article.
-
The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.Eur J Neurol. 2002 Jan;9(1):9-14. doi: 10.1046/j.1468-1331.2002.00346.x. Eur J Neurol. 2002. PMID: 11784369 Clinical Trial.
-
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.Mov Disord. 2005;20 Suppl 11:S11-6. doi: 10.1002/mds.20458. Mov Disord. 2005. PMID: 15822109 Review.
-
Motor fluctuations and dyskinesia in Parkinson's disease.Parkinsonism Relat Disord. 2001 Oct;8(2):101-8. doi: 10.1016/s1353-8020(01)00024-4. Parkinsonism Relat Disord. 2001. PMID: 11489675 Review.
Cited by
-
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.Health Psychol Res. 2022 Jun 28;10(3):36074. doi: 10.52965/001c.36074. eCollection 2022. Health Psychol Res. 2022. PMID: 35774903 Free PMC article.
-
Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats.Front Behav Neurosci. 2014 Oct 2;8:331. doi: 10.3389/fnbeh.2014.00331. eCollection 2014. Front Behav Neurosci. 2014. PMID: 25324746 Free PMC article.
-
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.Tremor Other Hyperkinet Mov (N Y). 2014 Jun 5;4:242. doi: 10.7916/D8KS6PPR. eCollection 2014. Tremor Other Hyperkinet Mov (N Y). 2014. PMID: 24932426 Free PMC article.
-
D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.Neurology. 2016 Jan 19;86(3):224-30. doi: 10.1212/WNL.0000000000002285. Epub 2015 Dec 30. Neurology. 2016. PMID: 26718579 Free PMC article.
-
Parkinson's disease.J Neurol Neurosurg Psychiatry. 1994 Jun;57(6):672-81. doi: 10.1136/jnnp.57.6.672. J Neurol Neurosurg Psychiatry. 1994. PMID: 7755681 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical